Envision Buyout Alert - National Securities Law Firm Seeks Higher Price for Envision Healthcare Shareholders in Connection with Proposed Buyout, and Encourages Shareholders to Contact Tripp Levy PLLC for More Information

NEW YORK, June 11, 2018 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the potential sale of Envision Healthcare Corp. (NYSE: EVHC) ("Envision" or the "Company") on behalf of its shareholders.  Envision announced that it has entered into a definitive agreement to be acquired by the private equity firm KKR in a cash deal valued at approximately $5.6 billion.  KKR will acquire Envision for $46 in cash per share.

Our investigation has determined that the offer price of only $46 per share, unfairly under-values the true going forward inherent value of Envision and that shareholders may not be receiving the maximum value for their shares.  Indeed, the book value alone of the Company is worth at least $53.93 per share and the stock reached a high of $64 per share this year.   The investigation further seeks to determine whether Envision's senior management is entering into this deal for their own self-interests to the detriment of the Company's shareholders.

If you are a shareholder of Envision and would like additional information as to how the proposed acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares at no cost, please contact us at:

Tripp Levy PLLC
New York, New York 
Toll free: 800-511-7037 
International: 602-241-2841 
Email: [email protected]  
www.tripplevy.com

Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and has assisted in the recovery of billions of dollars for shareholders in securities actions around the globe.

Attorney advertising. Prior results do not indicate a similar outcome.

SOURCE Tripp Levy PLLC

Related Links

http://www.tripplevy.com